View this email as a web page here.
            
Are you up to date on the latest developments in coronavirus therapies and diagnostics?
            
            
header-online_header6-06
Your update of the most recent news in drug discovery and development efforts
THURSDAY
June 4, 2020
2020-06-03_15-07-22
DDN_Hubspot_header_DiscoveryandDisease
Targeted drugs and immunotherapies may lower risk of hematologic cancers

Trend of reduced therapy-related hematologic cancers among patients with three cancer types likely driven by immune modulation, Roswell Park team proposes ...more >

Platform shows its mettle with kidney disease and COVID

Delta 4 announces that encouraging results have been achieved with its drug discovery 
technology ... more >

DDN_Hubspot_header_PreclinicalRnD
A boost for cancer immunotherapy

Engineers at the Massachusetts Institute of Technology design nanoparticles that stimulate the immune system and help it attack tumors ...more >

Aiming to better tackle relapse

Purdue startup gets $2-million SBIR grant to fast-track cancer drug platform technology ...more >

Radiation-induced lung injury: Is there finally an approved treatment on the way?

Aqualung Therapeutics receives a $2.3-million award to develop a novel therapeutic antibody for patients with radiation-induced lung injury...more >

Thermo NL - June 04  Reveal_-DDN_300x100
DDN_Hubspot_header_ClinicalTrials
COVID-19 helps boost the move toward virtual trials

ERT survey indicates many companies and organziations are implementing elements of virtual trials due to the pandemic ...more >

COVID-19 study funding extended after positive preliminary data

Study in California is utilizing IVIG as investigational coronavirus treatment for adults experiencing respiratory failure ...more >